1. Home
  2. CADL vs NCMI Comparison

CADL vs NCMI Comparison

Compare CADL & NCMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

HOLD

Current Price

$6.20

Market Cap

357.4M

Sector

Health Care

ML Signal

HOLD

Logo National CineMedia Inc.

NCMI

National CineMedia Inc.

HOLD

Current Price

$3.58

Market Cap

306.0M

ML Signal

HOLD

Company Overview

Basic Information
Metric
CADL
NCMI
Founded
1999
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Advertising
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
357.4M
306.0M
IPO Year
2021
2006

Fundamental Metrics

Financial Performance
Metric
CADL
NCMI
Price
$6.20
$3.58
Analyst Decision
Strong Buy
Buy
Analyst Count
7
4
Target Price
$19.00
$5.63
AVG Volume (30 Days)
1.7M
467.0K
Earning Date
05-14-2026
05-05-2026
Dividend Yield
N/A
3.38%
EPS Growth
58.62
52.17
EPS
N/A
N/A
Revenue
$125,000.00
N/A
Revenue This Year
N/A
$11.20
Revenue Next Year
N/A
$6.22
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.34
$2.92
52 Week High
$7.66
$5.92

Technical Indicators

Market Signals
Indicator
CADL
NCMI
Relative Strength Index (RSI) 56.36 60.85
Support Level $5.42 $3.17
Resistance Level $6.41 $3.77
Average True Range (ATR) 0.48 0.14
MACD 0.09 0.02
Stochastic Oscillator 49.22 72.83

Price Performance

Historical Comparison
CADL
NCMI

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

About NCMI National CineMedia Inc.

National CineMedia Inc is a cinema advertising platform in the U.S. It derives revenue from the sale of advertising to national, regional and local businesses through The Noovie Show and the CineLife Show, the cinema advertising and entertainment show seen on movie screens across the U.S., on LEN, a series of strategically-placed screens located in movie theater lobbies, as well as other forms of advertising and promotions in theater lobbies.

Share on Social Networks: